Yield10 Bioscience, Inc. (YTEN) reported Q3 EPS of ($0.71), $0.06 worse than the analyst estimate of ($0.65). Revenue for the quarter came in at $111 thousand versus the consensus estimate of $124.67 thousand.
Yield10 Bioscience, Inc. (YTEN) reported Q3 EPS of ($0.71), $0.06 worse than the analyst estimate of ($0.65). Revenue for the quarter came in at $111 thousand versus the consensus estimate of $124.67 thousand.